This article is more than 5 years old. Information may no longer be current.

Study shows Ellex 2RT safe, effective for treating diabetic macular edema

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ATLANTA — Six-month results of a study of the Ellex 2RT show the laser is safe and effective in the treatment of diabetic macular edema secondary to diabetic retinopathy, according to a press release here.

"Currently, this is the mildest laser therapy to be tested in a clinical setting which has demonstrated a selective and therapeutic effect on the retinal pigment epithelium," John Marshall, PhD, FRCOphth, FRCPath, said in a press release here at the American Academy of Ophthalmology meeting.

At 6 months, 46% of patients in the study showed a 5% decrease in central macular thickness and 43% of patients showed a two or more line increase in visual acuity, according to the release.